Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Total Liabilities
Everything the company owes to creditors and other parties.
Vivani Medical, Inc.NASDAQ: VANI
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities falls 2.4% from a year ago
Total liabilities stood at $23.27M at the end of Q1 FY2026, down 2.4% from a year earlier and down 1.7% from the prior quarter. Over 3 fiscal years it compounded at +51.4% a year.
Context
- Total liabilities amounted to 54.9% of total assets at the end of Q1 FY2026, down 12.3 pp from a year earlier.
- Total liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -2.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 23.66M USD
- Year-over-year change
- -1.2%
- 4-year CAGR
- +67.8%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.66M | -1.2% |
| FY2024 | 2024-12-31 | 23.95M | -4.3% |
| FY2023 | 2023-12-31 | 25.04M | +267.0% |
| FY2022 | 2022-12-31 | 6.82M | +128.3% |
| FY2021 | 2021-12-31 | 2.99M | — |
Total Liabilities vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -2.4% is the 7th highest of 8, against a peer median of +6.1%.
- Total liabilities amounts to 54.9% of total assets for VANI, versus a peer median of 22.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $74.71M USD | +0.8% | +75.5% | 144.9% | |
| Mar 2026 | $54.77M USD | +0.2% | +2.3% | 25.0% | |
| Mar 2026 | $30.57M USD | +299.9% | +43.7% | 11.4% | |
| Mar 2026 | $25.98M USD | +153.1% | +11.3% | 43.1% | |
| Mar 2026 | $23.27M USD | -2.4% | +51.4% | 54.9% | |
IMAImageneBio Inc | Mar 2026 | $13.36M USD | +6.1% | -7.8% | 9.8% |
| Mar 2026 | CA$7.22M CAD | -8.2% | -7.5% | 22.9% | |
| Mar 2026 | $3.96M USD | +104.1% | +21.1% | 5.1% | |
| Peer median (excluding VANI) | — | +6.1% | +11.3% | 22.9% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.